Your browser doesn't support javascript.
loading
A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment.
Byun, Ja Min; Kim, Ho Young; Nam, Seung-Hyun; Shin, Ho-Jin; Song, Seulki; Park, Jinny; Han, Sang Hoon; Park, Yong; Yuh, Young Jin; Mun, Yeung-Chul; Do, Young Rok; Sohn, Sang Kyun; Bae, Sung Hwa; Shin, Dong-Yeop; Yoon, Sung-Soo.
Afiliación
  • Byun JM; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Kim HY; Department of Internal Medicine, Hallym University Medical Center, Anyang, South Korea.
  • Nam SH; Department of Internal Medicine, Kyung Hee University at Gangdong, Seoul, South Korea.
  • Shin HJ; Division of Haematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, South Korea.
  • Song S; Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea.
  • Park J; Division of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea.
  • Han SH; Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, South Korea.
  • Park Y; Division of Hemato-Oncology, Department of internal medicine, Korea University School of Medicine, Seoul, South Korea.
  • Yuh YJ; Department of Internal Medicine, Inje University College of Medicine, Sanggye Paik Hospital, Seoul, South Korea.
  • Mun YC; Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, South Korea.
  • Do YR; Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, South Korea.
  • Sohn SK; Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea.
  • Bae SH; Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, South Korea.
  • Shin DY; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Front Oncol ; 12: 989984, 2022.
Article en En | MEDLINE | ID: mdl-36505839
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Suiza